Audits of the prevention and treatment of corticosteroid-induced osteoporosis in outpatients with rheumatic diseases in the West Midlands

被引:9
|
作者
Paskins, Z
Potter, T
Erb, N
Obrenovic, K
Rowe, IF
机构
[1] Univ Hosp Coventry, Dept Rheumatol, Coventry, W Midlands, England
[2] Warwickshire NHS Trust, Coventry, W Midlands, England
[3] Dudley Grp Hosp NHS Trust, Dudley, England
关键词
corticosteroid-induced osteoporosis; guidelines; regional audit;
D O I
10.7861/clinmedicine.6-2-183
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The management of corticosteroid-induced osteoporosis in rheumatology outpatients in the West Midlands was audited in relation to the 2002 Royal College of Physicians (RCP) Guidelines and re-audited in relation to the 1998 National Osteoporosis Society (NOS) Guidance. Practice was assessed from prospective data on all follow-up patients over a 2-week period in 13 rheumatology units. Data were analysed on 2,609 patients. Of the 626 patients fulfilling criteria for assessment against the RCP Guidelines, 351 (56.1%) were treated appropriately. The results do not allow for availability of, or wait for, DEXA scanning. Of 197 patients fulfilling the criteria for assessment against the NOS Guidance, 137 (69.5%) were treated appropriately, compared to 63% in a similar audit undertaken in 2000. Regional audit may facilitate clinical governance. These audits will inform discussion on both improving local practice and strengthening cases for improved osteoporosis services.
引用
收藏
页码:183 / 187
页数:5
相关论文
共 50 条
  • [1] Regional audits of the prevention of corticosteroid-induced osteoporosis in patients with rheumatic diseases in the West Midlands
    Paskins, Z
    Potter, T
    Obrenovic, K
    Erb, N
    Rowe, IF
    RHEUMATOLOGY, 2005, 44 : I32 - I33
  • [2] A regional audit of the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases in the West Midlands
    Erb, N
    Duncan, RC
    Raza, K
    Rowe, IF
    Kitas, GD
    Situnayake, RD
    RHEUMATOLOGY, 2002, 41 (09) : 1021 - 1024
  • [3] PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS IN CHILDREN WITH CHRONIC RHEUMATIC DISEASES
    FANTINI, F
    GATTINARA, M
    GALLAZZI, M
    GERLONI, V
    LOMATER, C
    MAZZOTTI, J
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 1109 - 1109
  • [4] Calcium, vitamin D and etidronate for the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases
    Loddenkemper, K
    Grauer, A
    Burmester, GR
    Buttgereit, F
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2003, 21 (01) : 19 - 26
  • [5] Successful prevention of corticosteroid-induced osteoporosis in children with chronic rheumatic diseases.
    Fantini, F
    Gattinara, M
    Gerloni, V
    Arnoldi, C
    Bellistri, A
    Aprile, L
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1252 - 1252
  • [6] Prevention and treatment of corticosteroid-induced osteoporosis
    Iwamoto, J
    Takeda, T
    Sato, Y
    YONSEI MEDICAL JOURNAL, 2005, 46 (04) : 456 - 463
  • [7] Bisphosphonates for the prevention and treatment of corticosteroid-induced osteoporosis
    Miller, PD
    OSTEOPOROSIS INTERNATIONAL, 2001, 12 : 3 - 10
  • [8] Risedronate for the prevention and treatment of corticosteroid-induced osteoporosis
    Dougherty, JA
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (03) : 512 - 516
  • [9] Bisphosphonates for the Prevention and Treatment of Corticosteroid-Induced Osteoporosis
    P. D. Miller
    Osteoporosis International, 2001, 12 (Suppl 3) : S3 - S10
  • [10] Prevention of corticosteroid-induced osteoporosis
    Birdsall, TC
    ANNALS OF INTERNAL MEDICINE, 1997, 127 (01) : 90 - 90